Feedback Sought on NIH Draft Resources to Support Participants in Implantable Device Trials

March 25, 2026

We seek your input on two resources aimed at supporting participants in NIH-funded implantable device clinical trials (NOT-OD-26-061). Comments on this Request for Information are voluntary and should be submitted electronically here until May 25, 2026. 

NIH views clinical research participants as vital partners in turning discovery into health.  Ensuring participant safety, rigorous research, and public trust are NIH’s highest priorities.  

The two new interconnected and complementary resources released today center around 

  • Considerations in Planning for the Post-Trial Needs of Research Participants who Receive an Investigational Implantable Device (Section 1)
  • Informed Consent for Research Using Investigational Implantable Devices (Section 2) 

Implant clinical trials have been increasingly used to study various medical conditions. But they also present unique ethical considerations and gaps in current clinical practices for participants that can extend beyond the duration of research studies. For instance, participants may face: 

  • Ongoing care needs after the study
  • Monitoring to reduce potential complications
  • Contending with future software and hardware compatibility
  • Potential device removal  

Your thoughts on these resources are welcome on any of the following: 

  • How useful these resources are
  • Their utility to support participants involved in implant clinical trials
  • Improving their ability to effectively communicate the potential benefits, risks, and outcomes associated with enrolling in such trials
  • Barriers to their voluntary adoption by researchers
  • Clarifying existing concepts or others that are missing 
  • Input on specific language in the proposed informed consent language 

NIH will consider the input received when finalizing the resources that support these trial participants after the implant study. Please keep in mind: 

  • Use of these resources is voluntary
  • Not intended to provide guidance on satisfying the regulatory requirements for the Protections of Human Subjects in the revised Common Rule or FDA's regulations governing the protection of human participants
  • Not intended to specify requirements for Institutional Review Boards when reviewing trials involving investigational implantable devices 
Questions? [email protected]
Categories: Top Stories

Related News

Here’s What We Heard About the Proposed Clinical Trial Specific Application Form, and What’s Next

Earlier this year, we asked the research community to weigh in on a proposed Clinical Trial Specific Application Form that would consolidate clinical trial information currently provided across two application components into a single, semi-structured form with page limits (NOT-OD-26-058). On behalf of the NIH Clinical Trials Application Working Group, I am pleased to share what we heard, and how your feedback will help shape our next steps.

Top Stories

FY25 Inclusion Data for NIH-Supported Clinical Research Now Available by NIH Spending Category

In May, we shared NIH-wide fiscal year (FY) 2025 enrollment data on the sex, race, ethnicity, and age of participants in NIH-supported clinical research, offering a broad view of inclusion across the NIH portfolio. More detailed FY25 enrollment data are now available through the NIH Research, Condition, and Disease Categorization (RCDC) Inclusion Statistics Report.

New Resources
For technical issues E-mail OER Webmaster